First Interventional Pulmonology Symposium of Cincinnati Set for Sept. 12
CINCINNATIThe University of Cincinnatis (UC) Division of Pulmonary, Critical Care and Sleep Medicine will host a regional symposium Saturday, Sept. 12, 2015, at the Kingsgate Marriott Conference Center, 151 Goodman Drive, to tackle current issues in interventional pulmonology.
"Our intent is to provide an annual exposure and review of a range of diagnostic and therapeutic procedures currently practiced in interventional pulmonology, says Sadia Benzaquen, MD, assistant professor in UCs Division of Pulmonary, Critical Care and Sleep Medicine and organizer of the event.
The diagnostic procedures will include convex EBUS, radial probe ultrasound and navigational bronchoscopy as a sampling for diagnosis, says Benzaquen. Therapeutic procedures in need of exposure and review are bronchial thermoplasty, endobronchial valve placement, thoracentesis with manometry and pleurX catheter placement, he explains.
"Institutional pulmonologists as well as community physicians can benefit greatly with an annual review of procedures and techniques, says Benzaquen, who will be among the presenters at the symposium.
Registration is required. The cost for a morning lecture for physicians is $150 while for others the cost is $75. A hands-on-experience session along with the lecture is available to physicians for $450. Space in this special session is limited to 20 physicians. To see a complete agenda or to register for the symposium, please visit
.
For additional information, email
or call
513-558-2475.
Among the presenters at the symposiums are: Julian Guitron, MD, assistant professor of surgery at UC; Adnan Majid, MD, director, interventional pulmonology, Beth Israel Deaconess Medical Center and associate professor at Harvard Medical School; Alejandro Aragaki, MD, interventional pulmonology fellow at UC; Francisco Almeida, MD, director, interventional pulmonary medicine, Cleveland Clinic; Shaheen Islam, MD, associate professor of clinical pulmonary, allergy, critical care and sleep at Ohio State University; and Ricardo Balestra, MD, University of Cincinnati.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.